Ophelia

Ophelia is a digital treatment provider for patients with opioid use disorder (OUD), committed to making evidence-based treatment universally accessible. Its mission is to remove barriers for the 80% of Americans with OUD who are unable to access care and the 50,000+ MAT-licensed clinicians who are unable to treat patients due to a lack of infrastructure, training, and support. At its core is the Ophelia Care Model, a team-based clinical model and software platform developed by leading experts in addiction medicine and psychiatry.

Ophelia is licensed to provide care in 27 states and contracted with Medicaid, Medicare, and Commercial insurers covering 75 million American lives. Ophelia is led by the nation’s leading experts in addiction treatment and backed by Tiger Global, Menlo Ventures, General Catalyst, Y Combinator, and founders of companies such as Flatiron Health, Carbon Health, PillPack, and Warby Parker. For more information, visit www.ophelia.com.